These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22547315)

  • 21. Update on ivabradine for heart failure.
    Borer JS; Tavazzi L
    Trends Cardiovasc Med; 2016 Jul; 26(5):444-9. PubMed ID: 26934996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.
    Pal N; Sivaswamy N; Mahmod M; Yavari A; Rudd A; Singh S; Dawson DK; Francis JM; Dwight JS; Watkins H; Neubauer S; Frenneaux M; Ashrafian H
    Circulation; 2015 Nov; 132(18):1719-25. PubMed ID: 26338956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of heart rate by cAMP sensitivity of HCN channels.
    Alig J; Marger L; Mesirca P; Ehmke H; Mangoni ME; Isbrandt D
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12189-94. PubMed ID: 19570998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical Use of Ivabradine.
    Koruth JS; Lala A; Pinney S; Reddy VY; Dukkipati SR
    J Am Coll Cardiol; 2017 Oct; 70(14):1777-1784. PubMed ID: 28958335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D
    Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular regulation and pharmacology of pacemaker channels.
    Bois P; Guinamard R; Chemaly AE; Faivre JF; Bescond J
    Curr Pharm Des; 2007; 13(23):2338-49. PubMed ID: 17692005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
    Thollon C; Bedut S; Villeneuve N; Cogé F; Piffard L; Guillaumin JP; Brunel-Jacquemin C; Chomarat P; Boutin JA; Peglion JL; Vilaine JP
    Br J Pharmacol; 2007 Jan; 150(1):37-46. PubMed ID: 17128289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function.
    Triggle CR
    Br J Pharmacol; 2008 Jun; 154(4):727-8. PubMed ID: 18438420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical results with I(f) current inhibition by ivabradine.
    Berdeaux A
    Drugs; 2007; 67 Suppl 2():25-33. PubMed ID: 17999561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
    Andrikopoulos G; Dasopoulou C; Sakellariou D; Tzeis S; Koulouris S; Kranidis A; Kappos K; Manolis AS
    Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):277-82. PubMed ID: 18221092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK; Gray D; Purcell H
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes.
    Scheruebel S; Koyani CN; Hallström S; Lang P; Platzer D; Mächler H; Lohner K; Malle E; Zorn-Pauly K; Pelzmann B
    J Mol Cell Cardiol; 2014 Jul; 72(100):64-73. PubMed ID: 24583250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G; Borovac JA; Vetrugno V; Camici PG; Crea F
    Int J Cardiol; 2017 Jun; 236():107-112. PubMed ID: 28256323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.